Dynamic Advisors Solutions boosted its stake in shares of iShares NASDAQ Biotechnology Index (ETF) (NYSE:IBB) by 14.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,772 shares of the company’s stock after buying an additional 218 shares during the period. Dynamic Advisors Solutions’ holdings in iShares NASDAQ Biotechnology Index (ETF) were worth $599,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the stock. Bridges Investment Management bought a new stake in iShares NASDAQ Biotechnology Index (ETF) during the fourth quarter worth approximately $545,000. Koshinski Asset Management raised its stake in iShares NASDAQ Biotechnology Index (ETF) by 4.7% in the fourth quarter. Koshinski Asset Management now owns 1,715 shares of the company’s stock worth $580,243 after buying an additional 77 shares during the last quarter. Harvest Management bought a new stake in iShares NASDAQ Biotechnology Index (ETF) during the third quarter worth approximately $607,000. Atria Investments raised its stake in iShares NASDAQ Biotechnology Index (ETF) by 40.2% in the fourth quarter. Atria Investments now owns 2,695 shares of the company’s stock worth $814,000 after buying an additional 773 shares during the last quarter. Finally, Carroll Financial Associates raised its stake in iShares NASDAQ Biotechnology Index (ETF) by 1.4% in the fourth quarter. Carroll Financial Associates now owns 2,584 shares of the company’s stock worth $874,000 after buying an additional 36 shares during the last quarter.

Shares of iShares NASDAQ Biotechnology Index (NYSE:IBB) opened at 282.08 on Wednesday. The company’s 50 day moving average price is $314.66 and its 200-day moving average price is $335.79. iShares NASDAQ Biotechnology Index has a 1-year low of $268.52 and a 1-year high of $400.79.

iShares Nasdaq Biotechnology ETF (NYSE:IBB), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

12 Month Chart for NYSE:IBB

Receive News & Ratings for iShares NASDAQ Biotechnology Index (ETF) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index (ETF) and related companies with MarketBeat.com's FREE daily email newsletter.